All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $120,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

HR 3160
PREVAIL Act
S 1553
PREVAIL Act

Lobbying activity 3

Health Issues

Issues relating to drug pricing proposals including implementation of the Inflation Reduction Act (P.L. 117-169); Rx oversight issues; PBM oversight issues; Issues related to budget reconciliation; Issues related to Most Favored Nation proposals; Issues related to the FTC.

Trade (domestic/foreign)

Issues related to IP protection; Market access issues related to PhRMA 232.

Issues related to patent reform legislation; H.R. 3160/S. 1553 - PREVAIL Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.